CD155 expression was significantly up-regulated in higher grade gliomas; specifically, WHO grade IV glioma (GBM) showed the highest expression, as compared to that in WHO grade II and grade III gliomas from the Rembrandt dataset (Figure 1A). This evidence concerns the gene PVR and glioma.